20
https://pubmed.ncbi.nlm.nih.gov/38114616
This study developed a PET-based risk assessment tool to predict outcomes in large B-cell lymphoma patients undergoing CAR T-cell therapy, incorporating extra-nodal involvement and metabolic tumor volume (MTV) to improve accuracy.